BusinessGalectin Therapeutics Announces Achievement of Key Milestones Related to NASH-CX Clinical TrialBy Nasdaq OMXFeb 1, 2017, 1:10 PM UTC
BusinessGalectin Therapeutics to Webcast Corporate Update At Annual Meeting of StockholdersBy Nasdaq OMXDec 8, 2016, 1:00 PM UTC
BusinessGalectin Therapeutics Announces Positive New Psoriasis and Atopic Dermatitis Clinical Data, Seeking Strategic Partnerships for Therapy of Severe Skin DiseasesBy Nasdaq OMXNov 10, 2016, 1:00 PM UTC
BusinessGalectin Therapeutics to Webcast Corporate Presentation at the MicroCap Conference on October 25 in PhiladelphiaBy Nasdaq OMXOct 17, 2016, 12:30 PM UTC
BusinessGalectin Therapeutics to Present Clinical Data on Selective Non-Invasive Tests for the Development of Novel Therapies for Nonalcoholic SteatohepatitisBy Nasdaq OMXOct 7, 2016, 12:30 PM UTC
BusinessGalectin Therapeutics to Present at Rodman & Renshaw 18th Annual Global Investment ConferenceBy Nasdaq OMXAug 31, 2016, 12:00 PM UTC
